Verano Holdings (VRNO) Gains from Investment Securities (2021 - 2024)
Verano Holdings (VRNO) reported Gains from Investment Securities of -$226000.0 for Q4 2024, up 96.56% year-over-year from -$114977.2 in Q1 2024, and up 96.56% quarter-over-quarter from -$6.6 million in Q4 2023.
Verano Holdings (VRNO) Gains from Investment Securities (2021 - 2024) Analysis & Trends
Verano Holdings (VRNO) has 4 years of Gains from Investment Securities data on file, last reported at -$226000.0 in Q4 2024.
- Gains from Investment Securities for Q4 2024 came in at -$226000.0, up 96.56% year-over-year; the trailing twelve-month figure through Dec 2025 was -$226000.0 (changed 0.0% YoY), and the FY2023 annual result was -$3.5 million, changed N/A from the prior year.
- Gains from Investment Securities climbed to -$226000.0 in Q4 2024 per VRNO's latest filing, from -$6.6 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $13.9 million in Q4 2022 and troughed at -$6.6 million in Q4 2023.
- A 4-year average of -$178000.0 and a median of -$2.1 million in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities jumped 402.52% in 2022, then slumped 147.19% in 2023.
- A 4-year view of Gains from Investment Securities shows it stood at -$4.6 million in 2021, then jumped by 402.52% to $13.9 million in 2022, then tumbled by 147.19% to -$6.6 million in 2023, then soared by 96.56% to -$226000.0 in 2024.
- Business Quant data shows VRNO's Gains from Investment Securities at -$226000.0 in Q4 2024, -$6.6 million in Q4 2023, and $6.6 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -226,000.00 |
| Dec 31, 2024 | -226,000.00 |
| Dec 31, 2023 | -6.57 Mn |
| Dec 31, 2023 | -6.57 Mn |
| Sep 30, 2023 | 6.57 Mn |
| Sep 30, 2023 | 6.57 Mn |
| Jun 30, 2023 | -4.06 Mn |
| Jun 30, 2023 | -4.06 Mn |
| Mar 31, 2023 | 593,000.00 |
| Mar 31, 2023 | 593,000.00 |
| Dec 31, 2022 | 13.93 Mn |
| Dec 31, 2022 | 13.93 Mn |
| Jun 30, 2022 | -6.00 Mn |
| Jun 30, 2022 | -6.00 Mn |
| Mar 31, 2022 | -4.76 Mn |
| Mar 31, 2022 | -4.76 Mn |
| Dec 31, 2021 | -4.60 Mn |
| Dec 31, 2021 | -4.60 Mn |
| Sep 30, 2021 | 3.35 Mn |
| Sep 30, 2021 | 3.35 Mn |